Statistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials
Zoe Moodie(Fred Hutch Cancer Center), Steven G. Self(Fred Hutch Cancer Center), Yunda Huang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lin Gu(Shanghai Public Health Clinical Center)
Cited by 69
Related Papers
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
|The Lancet|2008|708
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
|New England Journal of Medicine|2013|586
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557
Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study
|The Lancet Infectious Diseases|2011|385
Functions of IL-4 and Control of Its Expression
|Critical Reviews in Immunology|2017|354